No Prescription |
 |
 | ||
|
NUCOXIA Arcoxia |
|
| ||
No Prescription » Prescription Drugs 12 » NUCOXIA Arcoxia Etoricoxib which is a type of medicine known as a non-steroidal anti-inflammatory drug (NSAID).NSAIDs work by blocking the action of a substance in the body called cyclo-oxygenase. Cyclo-oxygenase is involved in producing prostaglandins in response to injury or certain diseases. These prostaglandins cause pain swelling and inflammation. Because NSAIDs block the production of these prostaglandins they are effective at relieving pain and inflammation.Cyclo-oxygenase does not only produce prostaglandins that cause inflammation. It also produces prostaglandins that have useful roles in the body. There are two different forms of cyclo-oxygenase COX-1 and COX-2. COX-2 is the form that (among other things) produces prostaglandins that cause inflammation. COX-1 does not produce inflammatory prostaglandins but does produce others that have useful effects including some that are involved in maintaining a healthy stomach and intestinal lining. Traditional NSAIDs such as ibuprofen or diclofenac block the action of both COX-1 and COX-2 and this is why they can sometimes cause side effects such as stomach irritation and peptic ulcers. Etoricoxib belongs to a new generation of NSAIDs that selectively block the action of COX-2. This means that it stops the production of inflammatory prostaglandins without stopping the production of prostaglandins that protect the stomach and intestines. It therefore reduces pain and inflammation but is less likely than traditional NSAIDs to cause side effects on the stomach and intestines (although such side effects are still possible).This medicine can be taken with or without food but may start to work quicker if taken without food.What is it used for?Acute gout Rheumatoid arthritis Osteoarthritis Buy NUCOXIA Arcoxia and other Prescription Drugs 12 products online at Medstore. Buy Online at Medstore - Click Here!
About NUCOXIA Arcoxia: Product Type: Prescription Drugs 12 NUCOXIA ( Arcoxia Generic Etoricoxib ) NUCOXIA (Arcoxia Generic Etoricoxib) Arcoxia Generic Etoricoxib 120 mg Tab Arcoxia Generic Etoricoxib NUCOXIA
View more Prescription Drugs 12 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
